ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Nov 5, 2015
Email Transaction Alerts
We’re making a few moves today.
Nov 5, 2015
Catching Up With Some of Our Best Ideas
Let’s take a look at the recent performance of a few companies within the Best Ideas Newsletter portfolio.
Nov 3, 2015
MLPs Breaking Out But More Questions
The data points continue to pile up against the sustainability of this business model…
Nov 3, 2015
Nov 3, 2015
US Oil Majors
Lower price realizations for major oil producers continue to pressure financial results. Though refining and chemical margins have improved, big oil exploration and production remains under significant pressure.
Oct 30, 2015
Strong Performance from Big Tobacco in Third Quarter
A number of big tobacco firms performed well in the third quarter of 2015, but industry-wide cigarette volume continued its downward trend.
Oct 28, 2015
Around the Horn in Biotech/Pharma: 3Q Earnings Review
Abbott, Biogen, Bristol-Myers, Eli Lilly, Gilead, GlaxoSmithKline, Merck, Pfizer…
Oct 27, 2015
Apple Owns the “Sixth Source” of an Economic Moat
Apple delivers yet again, beating fiscal fourth-quarter expectations by a large margin.
Oct 27, 2015
A 10%+ Cost of Capital for Midstream Equities Is Reality
Kinder Morgan floated equity capital at a cost of ~12%. The implications are far-reaching.
Oct 27, 2015
Explaining the New Page 2 of the Dividend Report
We've added another page to the dividend-report companion to the full 16-page report of each company. Let's walk through some of the new report specifics in the context of Best Ideas Newsletter portfolio holding Visa.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.